AMZN
Amazon.com, Inc.
AMZN has a slight edge over HRB overall, supported by stronger modeled upside and lower modeled downside.
HRB
H&R Block, Inc.
HRB offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
HRB Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Strong | |
| Healthy |
HRB's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over HRB in the historical PE scenario, which offers more potential upside but is not a forecast.
HRB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 8.3x | $50.73 | — |
| Cheap | 8.8x | $47.55 | -6.3% |
| Current | 9.4x | $50.73 | — |
| Fair | 13x | $69.30 | +37% |
| Expensive | 15x | $80.42 | +59% |
Historical ranges are pointers, not guarantees.
HRB's PE is in its cheap range at 9.4x. If earnings grow as analysts expect, today's price would be 8.3x next year's earnings.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
HRB Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
HRB has the edge over AMZN on the outlook, with more favorable valuation expectations.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over HRB on earnings, with more consistent year-over-year improvement.
HRB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.12 | +14% |
| Q3 2026 | $5.39 | +23% |
| Q2 2026 | $5.66 | +29% |
| Q1 2026 | $5.54 | +39% |
| Q4 2025 | $4.25 | +20% |
| Q3 2025 | $4.37 | +9.3% |
| Q2 2025 | $4.39 | +6.6% |
| Q1 2025 | $3.98 | -7.7% |
| Q4 2024 | $3.53 | -1.1% |
HRB earned $5.39 per share over the past year, up 23% from the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over HRB on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over HRB on profitability, with a higher operating margin.
HRB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $224.3M | +10% |
| Q2 2026 | $1.1B | +3% |
| Q1 2026 | $2.4B | +5.3% |
| Q4 2025 | $198.9M | +11% |
| Q3 2025 | $203.6M | +5% |
| Q2 2025 | $1.1B | +4.6% |
| Q1 2025 | $2.3B | +4.2% |
| Q4 2024 | $179.1M | 0% |
HRB's revenue has grown year over year for seven quarters in a row: $224M last quarter, up 10% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -103% | -1.7 points |
| Q2 2026 | 33% | -0.5 points |
| Q1 2026 | 43% | +0.3 points |
| Q4 2025 | -150% | +14 points |
| Q3 2025 | -102% | +16 points |
| Q2 2025 | 33% | +0.4 points |
| Q1 2025 | 43% | +0.5 points |
| Q4 2024 | -164% | -15 points |
HRB's operating margin was −103% last quarter, down 1.7 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
HRB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$379.2M | -$9.2M |
| Q2 2026 | $236.5M | -2% |
| Q1 2026 | $1.5B | +18% |
| Q4 2025 | -$649.5M | -$52.1M |
| Q3 2025 | -$370M | -$22.7M |
| Q2 2025 | $241.3M | -17% |
| Q1 2025 | $1.3B | -2.9% |
| Q4 2024 | -$597.4M | +$29.5M |
HRB has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
HRB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -4.5% | -5.8M shares |
| 1 year | -6.3% | -8.3M shares |
| 3 years | -16% | -23.2M shares |
| 5 years | -31% | -55M shares |
| Available history | -37% | -71M shares |
HRB has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over HRB on leverage, with a lower net debt burden relative to earnings.
HRB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.1x | Healthy |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 2.2x | Moderate |
| Q3 2025 | 1.4x | Healthy |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.8x | Very low |
| Q4 2024 | 2.2x | Moderate |
HRB's net debt is about 1.1 years of its operating earnings (EBITDA), down from 1.4 years a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
HRB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 60.3 | Neutral |
| Stochastic | 63.0 | Neutral |
HRB's weekly RSI is 60 (neutral) and its Stochastic is 63 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
HRB PE vs Consumer Cyclical Sector
| Metric | HRB | Sector median | Relative |
|---|---|---|---|
| PE | 9.4x | 18x | 48% below |
| PE % | 19 | 47 | 28 pts below |
HRB has the edge over AMZN on valuation relative to its sector.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN is in an uptrend: it's above all five of its weekly moving averages, and 40% above its 200-week average.
HRB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $47.6 | 6.5% above |
| 20 week MA | $46.6 | 8.8% above |
| 50 week MA | $40.4 | 26% above |
| 100 week MA | $47.0 | 7.9% above |
| 200 week MA | $46.5 | 9.2% above |
HRB is in an uptrend: it's above all five of its weekly moving averages, and 9.2% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has finished higher in five of the last six years, two of them by more than 50%. It's up 15% so far in 2026.
HRB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $23.4 | $15.5 | -34% |
| 2021 | $15.5 | $23.5 | +52% |
| 2022 | $23.5 | $39.2 | +66% |
| 2023 | $39.2 | $48.4 | +24% |
| 2024 | $48.4 | $53.4 | +10% |
| 2025 | $53.4 | $43.8 | -18% |
| 2026 YTD | $43.8 | $50.7 | +16% |
HRB has the edge over AMZN on returns for 2026, with the stronger performance.